Common Cold News and Research

RSS
Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Relatives of SARS-CoV-2 may pose a health threat for years to come

Relatives of SARS-CoV-2 may pose a health threat for years to come

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Singapore study finds virus-specific T cell immunity in recovered COVID-19 and SARS patients

Singapore study finds virus-specific T cell immunity in recovered COVID-19 and SARS patients

Cholesterol-lowering drugs show promise to lower COVID-19's threat

Cholesterol-lowering drugs show promise to lower COVID-19's threat

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

Coronavirus disease immunity fades within a few months, study finds

Coronavirus disease immunity fades within a few months, study finds

Oxford COVID-19 vaccine trials move to stage 3 human trials

Oxford COVID-19 vaccine trials move to stage 3 human trials

Human immune response could neutralize new G virus, shows study

Human immune response could neutralize new G virus, shows study

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

Which facemasks work best at stopping coronavirus?

Which facemasks work best at stopping coronavirus?

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

COVID-19 patients can rapidly generate virus-attacking T cells, shows study

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

First clinical trial in South Africa for Covid-19 vaccine begins

First clinical trial in South Africa for Covid-19 vaccine begins

Scientists show how harmless adenovirus disrupts the heart's electrical signaling

Scientists show how harmless adenovirus disrupts the heart's electrical signaling

WVU researchers develop new diagnostic and antibody tests for COVID-19

WVU researchers develop new diagnostic and antibody tests for COVID-19